SCHEMBL4900544

SCHEMBL4900544

CCN(c1nc(-c2ccc(C(F)(F)F)cc2)sc1C)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
HSP90AA1 P07900 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
GAA P10253 3/20 0.39
ALDH1A1 P00352 2/20 0.39
NPC1 O15118 1/20 0.39
HDAC8 Q9BY41 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PPARA Q07869 8/20 0.37
PPARD Q03181 7/20 0.37
PPARG P37231 4/20 0.36
RORC P51449 1/20 0.35
LMNA P02545 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895175 0.92 MAPT (0.36) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4907657 0.91 TRPM8 (0.41) RORC
SCHEMBL4905533 0.91 KDM4E (0.42) KDM4EMEN1MAPTKMT2AHSP90AA1
SCHEMBL4895425 0.91 TRPM8 (0.39) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4901379 0.91 KDM4E (0.41) KDM4EMEN1MAPTKMT2AHSP90AA1
SCHEMBL4899693 0.90 TP53 (0.40) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4901291 0.89 ALDH1A1 (0.39) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4898017 0.89 L3MBTL1 (0.41) KDM4EMEN1MAPTKMT2AGAA
SCHEMBL4900703 0.88 KDM4E (0.41) KDM4EMEN1MAPTKMT2AHSP90AA1
SCHEMBL4906349 0.87 ALDH1A1 (0.50) KDM4EMEN1MAPTKMT2AHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KDM4E 3750/4885MEN1 4859/4885MAPT 1858/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KDM4E 3834/4885MEN1 4855/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KDM4E 3834/4885MEN1 4855/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.